News

Task Force to Men: Don’t Get PSA Test   Oct. 7, 2011 — Men should just say "no" to prostate cancer screening with the common

An experimental drug developed by Bayer AG (BAYN) and Algeta ASA (ALGETA) prolonged the lives of men with prostate cancer that’s spread to their bones,

AUA Responds to New Recommendations on Prostate Cancer Screening PR Newswire LINTHICUM, Md., Oct. 7, 2011 Association urges men to speak with their physicians about

Coffee May Reduce Risk of Lethal Prostate Cancer in Men ScienceDaily (May 18, 2011) — Men who regularly drink coffee appear to have a lower

Five Genetic Variants Predict Aggressive Prostate Cancer August 19, 2011 — Prostate cancer is the second leading cause of cancer-related deaths in men, but one

Study shows Lycopene benefits for African American Men in Prostate Cancer Prevention In the first study of its kind, researchers at the University of Illinois

PCA3 May Help Predict Insignificant Prostate Cancer WASHINGTON, D.C.—Prostate cancer gene 3 (PCA3) may be a valuable predictor of pathologically confirmed low volume disease and

Clinically relevant family history changes between ages 30 and 50 affect screening recommendations
Clinically relevant family history changes between ages 30 and 50 affect screening recommendations

Clinically relevant family history changes between ages 30 and 50 affect screening recommendations

Primary Care Providers Ordering More PSA Tests WASHINGTON, D.C.—The rate of office-based PSA testing by primary care providers (PCPs) in the United States doubled from

Extensive PLND May Improve Prostate Cancer Outcomes The extent of pelvic lymph node dissection (PLND) significantly affects the likelihood of biochemical recurrence (BCR) in patients

Statin Therapy Tied to Lower Prostate Cancer Risk THURSDAY, June 23 (HealthDay News) — Statin therapy may decrease the risk and severity of prostate cancer,

Antifungal Drug May Help Men with Metastatic Prostate Cancer CHICAGO—Itraconazole, an oral antifungal drug, may keep prostate cancer (PCa) from worsening and delay the need

Cardiovascular Mortality Not Increased with ADT WASHINGTON, D.C.—Contrary to emerging evidence, a new study suggests that androgen deprivation therapy (ADT) does not increase the risk

Delay of Surgery in Men With Low Risk Prostate Cancer Purpose Treatment options for patients with low risk prostate cancer include radical prostatectomy, radiation therapy,

Obesity Raises Risk of Aggressive Prostate Cancer WASHINGTON, D.C.—Obesity is associated with a decreased risk of low-grade and increased risk of high-grade prostate cancer (PCa),

Prostate Cancer Risk Linked to Family History of Breast, Upper GI Cancer WASHINGTON, D.C.—It is known that men who have a family history of prostate

Mechanism for Link Between High Fat Diet and Risk of Prostate Cancer and Disorders Unveiled ScienceDaily (July 16, 2010) — Prostate cancer is the second

July 25, 2012 — In the past, clinicians and the public have heeded the advice of the United States Preventative Services Task Force (USPSTF) about

Circumcision Reduces Risk of Prostate Cancer MONDAY, March 12 (HealthDay News) — Circumcision prior to first sexual intercourse correlates with a reduced risk of prostate

PSA-based screening significantly decreases the risk of dying from prostate cancer (PCa), according to updated results of a large European study. The European Randomized Study

Gen-Probe has submitted a Premarket Approval Application (PMA) to the FDA for its PCA3 assay (Progensa), which may help determine the need for repeat prostate

Saturated fat negatively affects concentration; omega-3 fatty acids positively impact morphology

Statins May Lower Prostate Cancer Death Risk Men who take statins may have a lower risk of dying from prostate cancer (PCa), new findings suggest.